Data / Form D filings / Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc.: Form D filings
Synchronicity Pharma, Inc., a pharmaceuticals company in San Jose, CA, filed 9 Form D notices with the SEC between 2013 and 2022. The latest, on January 25, 2022, reports $1.6 million sold of a $3 million offering to 3 investors.
Find out what Synchronicity Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1416 Saratoga Avenue, #133, San Jose, CA, 95129
- Phone
- (650) 235-4140
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1593318
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 25, 2022 | New notice | $3,000,000 | $1,600,000 | $1,400,000 | 3 | Jan 11, 2022 | sec.gov |
| Oct 24, 2019 | New notice | $5,953,344 | $5,953,344 | $0 | 3 | Sep 18, 2019 | sec.gov |
| Jun 20, 2018 | New notice | $1,500,000 | $1,500,000 | $0 | 3 | Jun 13, 2018 | sec.gov |
| Feb 19, 2016 | New notice | $47,206,800 | $29,727,145 | $17,479,655 | 2 | Feb 18, 2016 | sec.gov |
| Oct 7, 2015 | Amendment | $12,000,000 | $9,100,000 | $2,900,000 | 2 | Jun 30, 2014 | sec.gov |
| Jun 1, 2015 | Amendment | $10,000,000 | $7,800,000 | $2,200,000 | 2 | Jun 30, 2014 | sec.gov |
| Jan 8, 2015 | Amendment | $6,500,000 | $5,000,000 | $1,500,000 | 2 | Jun 30, 2014 | sec.gov |
| Jul 25, 2014 | New notice | $3,000,000 | $306,831 | $2,693,169 | 2 | Jun 30, 2014 | sec.gov |
| Dec 3, 2013 | New notice | $15,989,400 | $14,796,231 | $1,193,169 | 2 | Nov 22, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Blair B Jackson | Director | |
| Steve B Kay | Director | |
| Frederick B Craves | Director | |
| Shu B Kurosaki | Executive Officer | |
| Glenn B Batchelder | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 24, 2022 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Synchronicity Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.